Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses

被引:186
作者
Cavani, A [1 ]
Nasorri, F [1 ]
Prezzi, C [1 ]
Sebastiani, S [1 ]
Albanesi, C [1 ]
Girolomoni, G [1 ]
机构
[1] IRCCS, Ist Dermopatico Immacolata, Immunol Lab, I-00167 Rome, Italy
关键词
allergic contact dermatitis; interleukin; 10; regulatory T cells;
D O I
10.1046/j.1523-1747.2000.00881.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The contribution of T helper (Th) and T cytotoxic (Tc) type 1 lymphocytes in the expression of allergic contact dermatitis to haptens has been amply documented. Conversely, the existence of T cell-based regulatory mechanisms has been poorly investigated. Here, we examined the properties of a subset of nickel-specific CD4(+) T cells displaying the cytokine profile (IL-10(+++), IL-5(+++), IFN-gamma(+/-), IL4(+/-)) of T regulatory cells 1 (Tr1) and with;he potential to down-modulate immune responses to nickel. Tr1 clones were isolated from skin challenged with NiSO4 and peripheral blood of nickel-allergic patients, and from the blood of healthy individuals. Tr1 clones expressed CD25, CD28, CD30, CD26, and the IL-12 receptor beta 2 chain upon activation, whereas the lymphocyte activation antigen-3 was present on 50% of the clones. Monocytes precultured with Tr1 cells in the presence of nickel, or treated with Tr1-derived supernatant, exhibited a markedly diminished capacity to stimulate nickel-specific Th1 responses. Tr1 supernatants also blocked the differentiation of dendritic cells (DC) from monocytes, as well as DC maturation and IL-12 production induced by lipopolysaccharide. As a consequence, the ability of DC to stimulate nickel-specific Th1 and Tc1 responses was greatly impaired. These inhibitory effects were completely prevented by IL-10, but not IL-5, neutralization. In aggregate, the results indicate that Tr1 cells can potently regulate the expression of Th1-mediated allergic diseases via release of IL-10.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 63 条
[51]  
Riemann H, 1996, J IMMUNOL, V156, P1799
[52]   Selective expression of an interleukin-12 receptor component by human T helper 1 cells [J].
Rogge, L ;
BarberisMaino, L ;
Biffi, M ;
Passini, N ;
Presky, DH ;
Gubler, U ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :825-831
[53]   T-CELL AND ANTIBODY-RESPONSE TO PARIETARIA-JUDAICA ALLERGENIC FRACTIONS IN ATOPIC AND NONATOPIC INDIVIDUALS [J].
SALLUSTO, F ;
QUINTIERI, F ;
PUGLIESE, O ;
REALE, G ;
PINI, C ;
DIFELICE, G .
ALLERGY, 1993, 48 (01) :37-44
[54]   Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α [J].
Sallusto, Federica ;
Lanzavecchia, Antonio .
JOURNAL OF IMMUNOLOGY, 2018, 200 (03) :887-896
[55]  
Scala E, 1998, J IMMUNOL, V161, P489
[56]   IN-VIVO EFFECTS OF INTERLEUKIN-10 ON CONTACT HYPERSENSITIVITY AND DELAYED-TYPE HYPERSENSITIVITY REACTIONS [J].
SCHWARZ, A ;
GRABBE, S ;
RIEMANN, H ;
ARAGANE, Y ;
SIMON, M ;
MANON, S ;
ANDRADE, S ;
LUGER, TA ;
ZLOTNIK, A ;
SCHWARZ, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (02) :211-216
[57]  
Steinbrink K, 1997, J IMMUNOL, V159, P4772
[58]   Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells [J].
Szabo, SJ ;
Dighe, AS ;
Gubler, U ;
Murphy, KM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :817-824
[59]  
TAGA K, 1993, BLOOD, V81, P2964
[60]   Inhibition of allergic contact dermatitis to DNCB but not to Oxazolone in interleukin-4-deficient mice [J].
Traidl, C ;
Jugert, F ;
Krieg, T ;
Merk, H ;
Nunzelmann, N .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) :476-482